MedTech News
AiMIFY™ AI MRI Software Earns CE Mark, Backed by Bracco and Subtle Medical
AI-powered solution aims to improve image quality and efficiency in MRI workflows across Europe
InspireMD wins CE Mark approval for CGuard Prime
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke.
AI tool analyzes blood DNA fragments for faster, affordable cancer monitoring
Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
First-of-its-kind device profiles newborns’ immune function
The BiophysicaL Immune Profiling for Infants (BLIPI) profiles an infant’s immune system in under 15 minutes, using just a single drop of blood.
MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications
TORONTO and TAIPEI, June 12, 2025 /PRNewswire/ — MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The clinical study demonstrates the transformative impact of MolecuLight’s i:X® device on the management of deep sternal wound infections (DSWI), showcasing significantly improved patient outcomes alongside cost savings and reduced burden on the healthcare system.
Sonata Scientific Unveils Helios MP500: Breakthrough Ethylene Oxide (EtO) Control Technology for Medical Device Sterilization Facilities
DANBURY, Conn., June 12, 2025 /PRNewswire/ — Sonata Scientific, a leader in advanced industrial air purification, today announced the launch of its revolutionary Helios MP500, a high-performance solution for eliminating fugitive ethylene oxide (EtO) emissions in medical device sterilization facilities. Tested and validated in real-world environments, the Helios technology platform consistently delivers destruction and removal efficiency (DRE) exceeding 99%, ensuring a safer environment for workers and surrounding communities.
Presidio wins FDA IDE for ultra-low frequency neuromod
Presidio Medical announced today that it received FDA investigational device exemption (IDE) for its ultra-low frequency (ULF) neuromodulation platform.
Lymph node on a chip: New immune system model may enhance precision medicine research
Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue found within a lymph node to study human health.